The PE Ratio as of December 2024 (TTM) for RespireRx Pharmaceuticals Inc. (RSPI) is -0.08

According to RespireRx Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.08. This represents a change of -57.64% compared to the average of -0.19 of the last 4 quarters.

RespireRx Pharmaceuticals Inc. (RSPI) Historical PE Ratio (quarterly & annually)

How has RSPI PE Ratio performed in the past?

The mean historical PE Ratio of RespireRx Pharmaceuticals Inc. over the last ten years is -1.02. The current -0.08 PE Ratio has changed 682.12% with respect to the historical average. Over the past ten years (40 quarters), RSPI's PE Ratio was at its highest in in the June 2014 quarter at 23.75. The PE Ratio was at its lowest in in the December 2013 quarter at -11.31.

RespireRx Pharmaceuticals Inc. (RSPI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of RespireRx Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RespireRx Pharmaceuticals Inc. (RSPI) Average PE Ratio

How has RSPI PE Ratio performed in the past?

The current PE Ratio of RespireRx Pharmaceuticals Inc. (RSPI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

RespireRx Pharmaceuticals Inc. (RSPI) PE Ratio vs. Peers

How is RSPI’s PE Ratio compared to its peers?

RespireRx Pharmaceuticals Inc.’s PE Ratio is less than Nascent Biotech, Inc. (0), greater than ProtoKinetix, Incorporated (-4.26), greater than Silo Pharma, Inc. (-9.65), greater than VG Life Sciences Inc. (-1.06), greater than Oxford Cannabinoid Technologies Holdings Plc (-20.33), greater than Neurobiological Technologies, Inc. (-0.19), less than Pharming Group N.V. (0), greater than Kane Biotech Inc. (-34.59), less than Health Sciences Group, Inc. (2.39), less than Protagenic Therapeutics, Inc. (0), greater than Sino Biopharmaceutical Limited (-0.41), less than ZIVO Bioscience, Inc. (32.87), greater than Cyteir Therapeutics, Inc. (-4.98), greater than Eledon Pharmaceuticals, Inc. (-9.12), less than null (18.44),

Build a custom stock screener for RespireRx Pharmaceuticals Inc. (RSPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RespireRx Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RespireRx Pharmaceuticals Inc. (RSPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RespireRx Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.